Conclusions

Based on data from the PHD, in-hospital mortality rates and length of hospital stay among patients with IPF were similar in the eras prior to and following FDA approval of antifibrotic drugs.
- More than 1 in 10 patients died during the index hospitalization.
- Median length of hospital stay was 5 days.
The risk of in-hospital mortality was higher in patients who were admitted to the ICU, who were attended by a critical care physician, who received mechanical ventilation, or who were being treated with IV steroids, IV antibiotics, or opioids.